Trial intelligence / Profile preview

Fruquintinib vs placebo in advanced non-squamous NSCLC (China, phase II)

CTR20140396Phase 2Completed

Sponsor

HUTCHMED

Start

Jun 2014

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1